2021
DOI: 10.3390/cancers13225790
|View full text |Cite
|
Sign up to set email alerts
|

A Novel Proton Pencil Beam Scanning FLASH RT Delivery Method Enables Optimal OAR Sparing and Ultra-High Dose Rate Delivery: A Comprehensive Dosimetry Study for Lung Tumors

Abstract: Purpose: While transmission proton beams have been demonstrated to achieve ultra-high dose rate FLASH therapy delivery, they are unable to spare normal tissues distal to the target. This study aims to compare FLASH treatment planning using single energy Bragg peak proton beams versus transmission proton beams in lung tumors and to evaluate Bragg peak plan optimization, characterize plan quality, and quantify organ-at-risk (OAR) sparing. Materials and Methods: Both Bragg peak and transmission plans were optimiz… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
43
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7

Relationship

5
2

Authors

Journals

citations
Cited by 28 publications
(43 citation statements)
references
References 31 publications
0
43
0
Order By: Relevance
“…In recent years, the field of radiation therapy (RT) has witnessed a reemergence of tremendous interest in the delivery of RT at ultrahigh dose rates (UHDRs), typically greater than 40 Gy/s, beginning with the publication of Favaudon et al 1 . This interest is sparked by a large body of preclinical results that suggest that such UHDR delivery yields comparable tumor control while substantially reducing normal tissue toxicity in in vivo animal models 1–20 . This differential response to radiation delivered at UHDR between tumor and normal tissue widens the therapeutic window and is dubbed by the FLASH effect 1 .…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, the field of radiation therapy (RT) has witnessed a reemergence of tremendous interest in the delivery of RT at ultrahigh dose rates (UHDRs), typically greater than 40 Gy/s, beginning with the publication of Favaudon et al 1 . This interest is sparked by a large body of preclinical results that suggest that such UHDR delivery yields comparable tumor control while substantially reducing normal tissue toxicity in in vivo animal models 1–20 . This differential response to radiation delivered at UHDR between tumor and normal tissue widens the therapeutic window and is dubbed by the FLASH effect 1 .…”
Section: Introductionmentioning
confidence: 99%
“…Also, transmission beams cannot spare the normal tissue at the distal edge of the target, which is validated by the comparison with conventional IMPT plans that place the Bragg peaks inside the targets. Although multiple-energy modulation as in conventional IMPT has not been available for FLASH-RT, using single-energy Bragg peak FLASH may provide a suitable solution to address the above issues, which we have evaluated by comparing the same dose metrics (23,39). Some previous in vivo and in vitro experiments (49)(50)(51) suggest that the FLASH effect may be triggered when a particular dose threshold is met; what is a clinically feasible dose fractionation is still not clear yet for liver cancers.…”
Section: Discussionmentioning
confidence: 99%
“…In proton FLASH-RT, transmission proton beams have been the most favorable choice of delivery owing to the sufficiently high beam current achievable with existing clinical systems. Recent efforts have reported combining transmission proton PBS with FLASH-RT, to translate the technology from bench to preclinic experiments, in aspects including proton systems (11)(12)(13)(14)(15), treatment planning (18)(19)(20)(21)(22)(23), and biological investigations (24,25). Proton PBS FLASH treatment planning plays a crucial role just as conventional treatment planning, but it faces new and unique challenges as the dose rate considerations must be included when evaluating the plan quality.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…This challenge could potentially be overcome by the higher dose rates brought forth by newer accelerator technologies. With proton systems capable of delivering non-transmission ultra-high-dose rates or FLASH treatment ( 14 ), we envision that such 3DCM would be very valuable for SRS/SBRT treatment, with the patient motion-related error eliminated or minimized.…”
Section: Discussionmentioning
confidence: 99%